ArticleBMC pregnancy and childbirth2026
Analysis of early morbidity and outcomes in macrosomic newborns.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
INTRODUCTION AND
aimTerm macrosomic newborns (≥ 4000 g) born between 37 and 42 weeks of gestation face greater risks of early neonatal morbidity and mortality than term infants with appropriate birth weights. Our study aimed to evaluate these outcomes specifically in term macrosomic newborns.
methodsFrom January 2022 to June 2023, we included singleton live-born infants with a birth weight ≥ 2500 g who were delivered at 37-42 weeks of gestation. The study group consisted of newborns with a birth weight ≥ 4000 g, while the control group was comprised of newborns with a birth weight of 2500-3999 g. Clinical and demographic data were prospectively collected from patient records and stored in an electronic database.
resultsOur study revealed a macrosomia frequency of 4.09% (43/1052). We identified a statistically significant positive correlation between maternal prepregnancy weight and neonatal birth weight (p < 0.05). Systolic and diastolic blood pressures were notably higher in the study group during the initial 15 min after birth (p < 0.05). Blood glucose levels decreased significantly in the study group during the first hour after birth (p < 0.01). History of lack of prenatal follow-up (66.6%) and cephalopelvic disproportion were significantly more prevalent in the macrosomic group (p < 0.05). No significant disparities concerning other morbidities were observed between the groups (p > 0.05). No mortality was documented in our study.
conclusionWe found that maternal prepregnancy weight demonstrated a statistically significant positive correlation with neonatal birth weight. Additionally, we noted a decrease in blood sugar levels during the first hour of life as birth weight increased, with significantly lower levels in the macrosomic group than in the control group. Furthermore, noninvasive arterial systolic/diastolic blood pressures measured within the first 15 min after birth in the delivery room were significantly higher in the macrosomic group than in the control group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.